文献速递垂体与肾上腺疾病

KDM1A缺失导致GIP依赖性双侧大结节性肾上腺增生伴库欣综合征

Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2021-10-13

这项多中心回顾性队列研究纳入17例GIP依赖性原发性双侧大结节性肾上腺增生伴库欣综合征患者,通过全基因组、全外显子及靶向测序发现所有患者携带KDM1A基因种系致病性变异,肾上腺病灶中同时存在KDM1A位点缺失,提示KDM1A双等位基因失活是该病的遗传驱动事件。

要点

  • GIP依赖性双侧大结节性肾上腺增生伴库欣综合征患者应检测KDM1A种系变异。
  • KDM1A双等位基因失活导致肾上腺病灶中GIP受体表达上调。
  • 建议对患者及其亲属提供遗传咨询和检测。

核心结论

  • GIP依赖性原发性双侧大结节性肾上腺增生伴库欣综合征由KDM1A双等位基因失活所致,符合抑癌基因模型。

研究设计与样本

  • 多中心回顾性队列研究,在法国、加拿大、意大利、希腊、比利时和荷兰的内分泌医院及大学医院开展。
  • 收集17例GIP依赖性原发性双侧大结节性肾上腺增生伴库欣综合征患者的血液和肾上腺样本。
  • 对照组包括29例无食物依赖性皮质醇升高的原发性双侧大结节性肾上腺增生患者及GIP依赖性单侧肾上腺皮质腺瘤患者。
  • 对血液和肾上腺DNA进行全基因组、全外显子及靶向二代测序和拷贝数分析,对肾上腺样本进行RNA测序,并在H295R细胞中进行功能分析。

主要发现

  • 所有17例患者均携带KDM1A基因种系杂合致病性或最可能致病性变异。
  • 这些患者肾上腺病灶中反复出现携带KDM1A位点的染色体1短臂缺失。
  • 29例对照组患者均无KDM1A种系或体细胞改变。

关键数值与推荐

  • KDM1A基因种系致病性或最可能致病性变异在17例患者中全部检出。
  • 对照组29例均未检出KDM1A种系或体细胞改变。

临床怎么用

  • 对GIP依赖性原发性双侧大结节性肾上腺增生伴库欣综合征患者应进行KDM1A基因检测。
  • 应为此类患者及其亲属提供遗传咨询。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome is caused by aberrant expression of the GIP receptor in adrenal lesions. The bilateral nature of this disease suggests germline genetic predisposition. We aimed to identify the genetic driver event responsible for GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome. METHODS: We conducted a multicentre, retrospective, cohort study at endocrine hospitals and university hospitals in France, Canada, Italy, Greece, Belgium, and the Netherlands. We collected blood and adrenal samples from patients who had undergone unilateral or bilateral adrenalectomy for GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome. Adrenal samples from patients with primary bilateral macronodular adrenal hyperplasia who had undergone an adrenalectomy for overt or mild Cushing's syndrome without evidence of food-dependent cortisol production and those with GIP-dependent unilateral adrenocortical adenomas were used as control groups. We performed whole genome, whole exome, and targeted next generation sequencing, and copy number analyses of blood and adrenal DNA from patients with familial or sporadic disease. We performed RNA sequencing on adrenal samples and functional analyses of the identified genetic defect in the human adrenocortical cell line H295R. FINDINGS: 17 patients with GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome were studied. The median age of patients was 43·3 (95% CI 38·8-47·8) years and most patients (15 [88%]) were women. We identified germline heterozygous pathogenic or most likely pathogenic variants in the KDM1A gene in all 17 patients. We also identified a recurrent deletion in the short p arm of chromosome 1 harboring the KDM1A locus in adrenal lesions of these patients. None of the 29 patients in the control groups had KDM1A germline or somatic alterations. Concomitant genetic inactivation of both KDM1A alleles resulted in loss of KDM1A expression in adrenal lesions. Global gene expression analysis showed GIP receptor upregulation with a log2 fold change of 7·99 (95% CI 7·34-8·66; p=4·4 × 10-125), and differential regulation of several other G protein-coupled receptors in GIP-dependent primary bilateral macronodular hyperplasia samples compared with control samples. In vitro pharmacological inhibition and inactivation of KDM1A by CRISPR-Cas9 genome editing resulted in an increase of GIP receptor transcripts and protein in human adrenocortical H295R cells. INTERPRETATION: We propose that GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome results from a two-hit inactivation of KDM1A, consistent with the tumour suppressor gene model of tumorigenesis. Genetic testing and counselling should be offered to these patients and their relatives. FUNDING: Agence Nationale de la Recherche, Fondation du Grand défi Pierre Lavoie, and the French National Cancer Institute.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Chasseloup F, Bourdeau I, Tabarin A, et al. Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study. Lancet Diabetes Endocrinol. 2021. PMID: 34655521. doi:10.1016/S2213-8587(21)00236-9

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。